News
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease PR Newswire
View ArticlePfizer's Multibillion-Dollar Blockbuster Set to Grow
Pfizer's Multibillion-Dollar Blockbuster Set to Grow Motley Fool
View ArticlePfizer: FDA delays new Prevnar ruling to Jan. 2012
Pfizer: FDA delays new Prevnar ruling to Jan. 2012 Yahoo/AP
View ArticleDrugmakers extend cut-price pneumonia vaccine deal
Drugmakers extend cut-price pneumonia vaccine deal Reuters
View ArticleFDA clears Pfizer vaccine for adults over 50
FDA clears Pfizer vaccine for adults over 50 Yahoo/AP
View ArticlePfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In...
Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years Yahoo/BusinessWire
View ArticlePfizer completes pneumococcal pneumonia case accrual for CAPiTA
Pfizer completes pneumococcal pneumonia case accrual for CAPiTA The Fly on the Wall
View Article
More Pages to Explore .....
